Phenotyping technologies save on costs and improve rare disease workflows
Dekel Gelbman, CEO of FDNA, was featured in Becker’s Hospital Review, discussing the value of phenotyping to hospitals involved in rare disease workflows. Below is an excerpt: Diagnosing rare diseases is like solving a puzzle, with physicians trying to fit together many complex clues. Unfortunately, the 10% of the population who suffer from a rare […]